This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Clindamycin Phosphate

Read time: 1 mins
Marketing start date: 23 Nov 2024

Summary of product characteristics


Effective Time

20230920

Version

1

Spl Product Data Elements

Clindamycin Phosphate clindamycin phosphate CLINDAMYCIN PHOSPHATE CLINDAMYCIN ALLANTOIN CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) METHYLPARABEN POLYETHYLENE GLYCOL 400 PROPYLENE GLYCOL SODIUM HYDROXIDE WATER

Application Number

ANDA216587

Brand Name

Clindamycin Phosphate

Generic Name

clindamycin phosphate

Product Ndc

70771-1855

Product Type

HUMAN PRESCRIPTION DRUG

Route

TOPICAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Clindamycin Phosphate Gel USP, 1% 30 g NDC 70771-1855-2 Rx only tube label carton label

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.